Migdal Insurance & Financial Holdings Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$163M |
| 2 |
iShares Currency Hedged MSCI Emerging Markets
HEEM
|
+$63.3M |
| 3 |
TransDigm Group
TDG
|
+$49.2M |
| 4 |
Vanguard Information Technology ETF
VGT
|
+$40.7M |
| 5 |
Apple
AAPL
|
+$26.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$330M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$108M |
| 3 |
Perrigo
PRGO
|
+$42.6M |
| 4 |
iShares Latin America 40 ETF
ILF
|
+$35.8M |
| 5 |
iShares Residential and Multisector Real Estate ETF
REZ
|
+$27.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.22% |
| 2 | Healthcare | 11.43% |
| 3 | Financials | 10.6% |
| 4 | Communication Services | 4.16% |
| 5 | Industrials | 3.86% |
Similar funds
Migdal Insurance & Financial Holdings's Q3 2017 Portfolio in Review
As of Q3 2017, Migdal Insurance & Financial Holdings held 603 positions worth $4.22B, down 4.1% from $4.4B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Migdal Insurance & Financial Holdings withdrew a net $213M in Q3 2017, closing 59 positions and reducing 169 holdings. Its most notable exit was Kite Pharma, Inc., an estimated $15.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Migdal Insurance & Financial Holdings opened a new position in iShares Core MSCI Emerging Markets ETF worth $166M.
- Migdal Insurance & Financial Holdings's largest Q3 2017 buy was iShares Core MSCI Emerging Markets ETF: 3,065,098 shares worth $166M.
- Migdal Insurance & Financial Holdings added most to iShares Currency Hedged MSCI Emerging Markets in Q3 2017, an estimated $63.3M increase.
- Migdal Insurance & Financial Holdings's biggest Q3 2017 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $330M.
- Migdal Insurance & Financial Holdings fully exited Kite Pharma, Inc. in Q3 2017, selling an estimated $15.2M.
- Migdal Insurance & Financial Holdings's ten largest holdings make up 33% of its $4.22B portfolio in Q3 2017.
- Migdal Insurance & Financial Holdings opened 142 new positions and closed 59 in Q3 2017.
- Migdal Insurance & Financial Holdings's portfolio value fell 4.1% quarter-over-quarter to $4.22B.
Based on Migdal Insurance & Financial Holdings's 13F filing for Q3 2017, filed 6 Nov 2017.